drugset / Trial / NCT00162032
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging (MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of developing cardiac events.
Timeline
- Start
- 2005-08
- Primary completion
- 2010-05
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TECHNETIUM SESTAMIBI | Diagnostic / imaging agent | — | — |